PHARMACEUTICAL ASSOCIATION COMPRISING A GROWTH FACTOR RECEPTOR AGONIST CONJUGATED TO A BIOACTIVE CARRIERFOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF - Patent 3349777

(19)

(11)

EP 3 349 777 A2

(12)

(88)	Date of publication A3:
	22.06.2017

(43)	Date of publication:
	25.07.2018 Bulletin 2018/30

(21)	Application number: 16770462.6

(22)	Date of filing: 15.09.2016

(51)

International Patent Classification (IPC):

A61K 38/05^(2006.01)
A61L 27/34^(2006.01)
A61K 38/08^(2006.01)
A61K 38/12^(2006.01)
A61K 38/18^(2006.01)
G06F 19/16^(2011.01)

A61L 27/12^(2006.01)
A61K 38/07^(2006.01)
A61K 38/10^(2006.01)
A61L 27/54^(2006.01)
A61K 9/16^(2006.01)

(86)	International application number:
	PCT/EP2016/071785

(87)	International publication number:
	WO 2017/046219 (23.03.2017 Gazette 2017/12)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	MA MD

(30)

Priority:

17.09.2015 US 201562219716 P

(71)	Applicant: Histide AG
	8834 Schindellegi (CH)

(72)	Inventors:
	ZOUANI, Omar F. 8834 Schindellegi (CH) GOCHEVA, Veronika 8834 Schindellegi (CH)

(74)	Representative: Cabinet Beau de Loménie
	158, rue de l'Université 75340 Paris Cedex 07 75340 Paris Cedex 07 (FR)

(54)	PHARMACEUTICAL ASSOCIATION COMPRISING A GROWTH FACTOR RECEPTOR AGONIST CONJUGATED TO A BIOACTIVE CARRIERFOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF